Evaluation of Intracellular Signaling Downstream Chimeric Antigen Receptors

CD19-targeting CAR T cells have shown potency in clinical trials targeting B cell leukemia. Although mainly second generation (2G) CARs carrying CD28 or 4-1BB have been investigated in patients, preclinical studies suggest that third generation (3G) CARs with both CD28 and 4-1BB have enhanced capaci...

Descripción completa

Detalles Bibliográficos
Autores principales: Karlsson, Hannah, Svensson, Emma, Gigg, Camilla, Jarvius, Malin, Olsson-Strömberg, Ulla, Savoldo, Barbara, Dotti, Gianpietro, Loskog, Angelica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689545/
https://www.ncbi.nlm.nih.gov/pubmed/26700307
http://dx.doi.org/10.1371/journal.pone.0144787

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689545/
https://www.ncbi.nlm.nih.gov/pubmed/26700307
http://dx.doi.org/10.1371/journal.pone.0144787

Ejemplares similares